MSCV-NPM-ALK-IRES-mCherry
(Plasmid
#262241)
-
PurposeRetroviral expression plasmid used to express NPM-ALK
-
Depositing Lab
-
Depositing OrganizationPeter MacCallum Cancer Institute
Located in Australia -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 262241 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneMSCV
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersmcherry
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site BamHI (unknown if destroyed)
- 5′ sequencing primer cccttgaacctcctcgttcgacc
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2025.02.10.637348 for bioRxiv preprint.
mCherry sequence contains K4M and G5D mutations (relative to NCBI WP_046072766.1), they do not affect the function of the plasmid.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MSCV-NPM-ALK-IRES-mCherry was a gift from Mohamed Fareh (Addgene plasmid # 262241 ; http://n2t.net/addgene:262241 ; RRID:Addgene_262241) -
For your References section:
Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition. Hu 胡文欣 W, Chen 陈竑霖 H, He S, Casan JML, Shembrey C, Li S, Brown LM, Zhao A, Truong L, Buchner I, Vassiliadis D, Hughes TP, White DL, Carmichael CL, De Weck A, Voskoboinik I, Gouil Q, Trapani JA, Ekert PG, Sadras T, Fareh M. Sci Adv. 2026 Oct 16;12(42):eady0296. doi: 10.1126/sciadv.ady0296. Epub 2026 Oct 16. 10.1126/sciadv.ady0296 PubMed 42886793